Functional gene description:
Transcriptional enhancer factors (TEFs)-4 and -5 (HUGO/GDB-approved gene symbols TEAD2 and TEAD3, respectively) belong to a family of transcription factors containing the TEA DNAbinding domain (3) . This family comprises two other members designated TEF-1 and TEF-3 (renamed TEAD1 and TEAD4) (3, 4) . First identified in the simian virus 40 enhancer, TEAD-binding sites have been principally studied in cardiac and skeletal muscle-specific promoters where they are referred to as M-CAT sites. The TEADs are expressed in different but partially overlapping patterns during mouse embryogenesis (3) (4) (5) , most notably in skeletal and cardiac muscle, mitotic neuroblasts, and placenta. Mouse Tead2 is strongly expressed throughout the embryo from the onset of zygotic gene expression, while Tead3 is expressed in the extraembryonic tissues, notably the trophoblast giant cells and the labyrinthine region of the placenta (5). Human TEAD3 is expressed in the placental syncytiotrophoblast, and it is upregulated during trophoblast differentiation in vitro (5 Name of clone or DNA source: The TEAD2 genomic probe was isolated as a phage from a human genomic DNA library, and the TEAD3 cDNA was isolated from a human placental cDNA library.
Description of clone or DNA: The TEAD2 probe was a GEM phage with a Ͼ10-kb portion of the TEAD 2 genomic locus. The TEAD3 probe was a 3-kb cDNA clone containing the entire open reading frame along with the 5Ј and 3Ј untranslated regions. Method used to validate gene identity: The GenBank accession numbers for TEAD2 and TEAD3 are X94440 and X94439, respectively.
Methods of mapping:
The chromosomal assignment of TEAD2 and TEAD3 was performed by both fluorescence in situ hybridization (FISH) and radiation hybrid panel analyses.
FISH experiments were performed essentially as described by Pinkel et al. (8) . Metaphase spreads were prepared from phytohemagglutinin-stimulated human lymphocytes, cultured at 37°C for 72 h. 5-Bromodeoxyuridine was added for the final 7 h of culture (60 g/ml of medium) to ensure good chromosomal R-banding. The TEAD2 probe was prepared by nick-translation of a purified phage containing a Ͼ10-kb insert of the TEAD2 gene in GEM with biotin-16 -dUTP (outlined by the Boehringer Mannheim protocol). The biotinylated TEAD3 probe comprised a 3-kb cDNA fragment in pEXlox. Hybridized probe was detected by fluorescence isothiocyanate-conjugated avidin (Vector Laboratories). Chromosomes were counterstained and R-banded with propidium iodide diluted in antifade solution, pH 11.0, as described (6) .
To refine further the localization of the TEAD2 and TEAD3 genes, we used the GeneBridge 4 radiation hybrid panel (Whitehead Institute, Research Genetics, Inc.). For TEAD2, PCR amplifications were performed using a primer pair in exon 8, generating a 154-bp product (forward primer 5Ј-CCTGTTCGTGCACATCAGC-3Ј and reverse primer 5Ј-GAC-CAGGAAGAAGGCATGG-3Ј), and for TEAD3, a primer pair in the 3Ј untranslated region generating a 366-bp product was used (forward primer 5Ј-AGCCTCGCGTGACCTCAGA-3Ј and reverse primer 5Ј-CCCTGGATGAGAACTCCAG-3Ј). Thirty-five cycles of polymerase chain reaction for TEAD2 were performed at 94°C for 45 s, 63°C for 45 s, and 72°C for 45 s. For TEAD3, annealing was performed at 58°C for 45 s.
Results: A total of 30 metaphase cells were analyzed for each probe. For TEAD2, 90% of the cells showed specific fluorescent spots on the subdistal band of the long arm of chromosome 19, band q13.3 (Fig. 1A) . The TEAD2 gene therefore maps close to the ERCC1, ERCC2, R-RAS, and SNRP70 genes. A search for linkage homology between the mouse chromosome 7 region where the Tead2 gene was located and the human 19q13.3 region revealed the presence of the murine equivalents of the above four markers, indicating that these two regions are indeed syntenic. For TEAD3, specific fluorescent spots were present on 90% of the cells on the 6p21.2 band (Fig. 1B) . Thus, TEAD3 maps close to the oncogene PIM1 and cyclin-dependent kinase inhibitor 1A (CIP1/WAF1), genes both present on 6p21.2.
The results of the radiation hybrid experiments using the sequence-tagged site database at the Whitehead Institute confirmed the localization obtained by FISH. TEAD2 was localized between the anonymous markers D19S412 and D19S210, 2.33 cR telomeric from NIB1805 (lod score Ͼ3). The marker D19S412 (1) previously mapped to 19q13.3, is located 5.4 cR centromeric to TEAD2. TEAD3 was localized 2.74 cR centromeric from NIB 1566 between D6S291 and D6S271 (lod score Ͼ3). The marker D6S273, which is localized in the interval 6p21.2-p11 (7) is 26.6 cR telomeric to the TEAD3 locus, confirming that TEAD3 is located on 6p21.2. Further confirmation of this localization came from the mapping of the murine Tead 3 gene to chromosome 17 in a region syntenic to human chromosome 6p21.2 (manuscript in preparation).
Additional comments: The related TEAD1 and TEAD4 genes have been mapped to chromosomes 11p15.4 and 12p13.2-p13.3, respectively (9), paralogous regions of the human genome resulting from an ancient chromosome duplication, where the myogenic MyoD, myf 5, and myf 6 genes are also located.
Homologies: Mouse Tead2 (also called ETF) and Tead4 are located on chromosomes 7 and 6, respectively (2, 10) . Linkage homology between human and mouse indicates that the Tead1 gene may also be present on mouse chromosome 7.
